PERSPECTIVE
Published on 12 Mar 2021
Autologous Stem Cell Transplantation for Myeloma: Cytoreduction or an Immunotherapy?
doi 10.3389/fimmu.2021.651288
- 4,482 views
- 10 citations
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- T Cells in Plasma Cell Disorders
T Cells in Plasma Cell Disorders
16k
Total downloads
49k
Total views and downloads
Articles
MINI REVIEW
Published on 05 Mar 2021
Understanding the Role of T-Cells in the Antimyeloma Effect of Immunomodulatory Drugs
doi 10.3389/fimmu.2021.632399
- 9,466 views
- 35 citations
REVIEW
Published on 26 Feb 2021
Co-evolution of Immune Response in Multiple Myeloma: Implications for Immune Prevention
doi 10.3389/fimmu.2021.632564
- 4,334 views
- 13 citations
ORIGINAL RESEARCH
Published on 25 Feb 2021
Increased Immune-Regulatory Receptor Expression on Effector T Cells as Early Indicators of Relapse Following Autologous Stem Cell Transplantation for Multiple Myeloma
doi 10.3389/fimmu.2021.618610
- 3,127 views
- 9 citations
MINI REVIEW
Published on 23 Feb 2021
Treg and Oligoclonal Expansion of Terminal Effector CD8+ T Cell as Key Players in Multiple Myeloma
doi 10.3389/fimmu.2021.620596
- 4,378 views
- 16 citations
MINI REVIEW
Published on 15 Feb 2021
Bystander Memory T Cells and IMiD/Checkpoint Therapy in Multiple Myeloma: A Dangerous Tango?
doi 10.3389/fimmu.2021.636375
- 2,743 views
- 5 citations
REVIEW
Published on 23 Dec 2020
Toxicities of Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma: An Overview of Experience From Clinical Trials, Pathophysiology, and Management Strategies
doi 10.3389/fimmu.2020.620312
- 8,771 views
- 33 citations
ORIGINAL RESEARCH
Published on 03 Sep 2020
Conventional Treatment for Multiple Myeloma Drives Premature Aging Phenotypes and Metabolic Dysfunction in T Cells
doi 10.3389/fimmu.2020.02153
- 3,514 views
- 27 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore